top of page
JAMMU UNIT-3
UPCOMING
UNIT 3
Zeiss Pharma Ltd. is an upcoming, state-of-the-art facility designed to manufacture a wide range of Carbapenems and Penicillins, with a focus on tablets, dry powder injections, and capsules. Built in strict adherence to EU GMP guidelines, this advanced plant reflects our unwavering commitment to quality and regulatory compliance. The primary objective of Unit-3 is to cater exclusively to our international clients, ensuring that we continue to meet the growing global demand for high-quality pharmaceutical products. By leveraging cutting-edge technology and robust manufacturing processes, we aim to expand our export capabilities and strengthen our position as a trusted partner for healthcare companies around the world.

bottom of page